Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

PI3Kα/δ Inhibitor, Copanlisib, Inhibits Acute Lymphoblastic Leukemia Cell Growth, Increases Survival and Inhibits CNS Disease Progression in Leukemic Mice

Sarah Ridge, PhD, Hisayuki Yao, PhD, Trevor T Price, PhD, Andrew E Whiteley, PhD, Maegan Burns, Dorothy A. Sipkins, MD

Blood (2019) 134 (Supplement_1): 2758.

https://doi.org/10.1182/blood-2019-132097

Published: 2019

Journal Articles

Risk Stratification and Transfusion Dependence Are Independent Risk Factors for Cardiovascular Disease (CVD) in Myelodysplastic Syndrome (MDS)

Diego Adrianzen Herrera, MD, Kith Pradhan, PhD, Rosebella Snyder, MD, Siddharth Karanth, MBBS, MPH, DrPH, Murali Janakiram, MD MS, Ioannis Mantzaris, MD MS, Santosh Murthy, MD MPH, Amit Verma, MBBS, Aditi Shastri, MD

Blood (2019) 134 (Supplement_1): 336.

https://doi.org/10.1182/blood-2019-123317

Published: 2019

Journal Articles

The Combination of PARP Inhibitors and DNMT Inhibitors Modulates Immune Activity and Suggests a Role for Immune Therapy in AML

Aksinija A Kogan, BS, MS, Michael Topper, BS, Susannah C Shissler, BS, Michael S Lee, BS, Dominique R Bollino, BS, Eun Yong Choi, Rena G Lapidus, PhD, Li Li, MD PhD, Donald Small, MD PhD, Maria R. Baer, MD, Tonya J Webb, PhD, Stephen Baylin, MD, Feyruz V. Rassool, BSc, PhD

Blood (2018) 132 (Supplement 1): 3886.

https://doi.org/10.1182/blood-2018-99-117294

Published: 2018

Journal Articles

Targeting CD20+ Relapsed Refractory B Cell Lymphoma with ACTR087, Antibody-Coupled T-Cell Receptor (ACTR) Engineered Autologous T Cells, in Combination with Rituximab

Heather A Huet, PhD, Casey Judge, M.S., R. Anthony Barnitz, PhD, Ryan Boomer, BSc, Kathleen McGinness, PhD, John Shin, BSc, Tooba Cheema, PhD, Kathleen Whiteman, M.S., Birgit Schultes, PhD, Ann Ranger, PhD, Lan Cao, PhD, Geoffrey Hodge, PhD, Michael J. Vasconcelles, MD, Seth A Ettenberg, PhD

Blood (2016) 128 (22): 3512.

https://doi.org/10.1182/blood.V128.22.3512.3512

Published: 2016

Journal Articles

Alisertib-Induced Polyploidy and Senescence in DH/DP-DLBCL Is Abrogated By Synthetic Lethal Interactions with Ibrutinib and Rituximab

Shariful Islam, MS, Wenqing Qi, PhD, Carla Morales, B.S., Laurence Cooke, M.S., Manjari Pandey, MD, Catherine M. Spier, MD, Daruka Mahadevan, MD PhD

Blood (2016) 128 (22): 5397.

https://doi.org/10.1182/blood.V128.22.5397.5397

Published: 2016

Journal Articles

Influence of Different Components of the Tumor Microenvironment on Human Patient-Derived Lymphoma Cell Engraftment in Immmunodeficient Mice

Cordula Tschuch, PhD, Kerstin Klingner, Dorothee Lenhard, Cyrill Rentsch, MD PhD, Christian Wetterauer, Lukas Bubendorf, MD, Tatjana Vlajndic, MD, Milena Pantic, PhD, Lisa K Isbell, MD, Nikolas von Bubnoff, MD, Teppo Haapaniemi, PhD, Julia B. Schueler, DVM, PhD

Blood (2015) 126 (23): 1459.

https://doi.org/10.1182/blood.V126.23.1459.1459

Published: 2015

Journal Articles

5-Azacytidine Reduces Leukemic Burden in a Xenograft Model of Juvenile Myelomonocytic Leukemia

Christopher Felix Krombholz, Angelina Meier, Konrad Aumann, Silvia Fluhr, Matthias Kollek, Daniel B Lipka, Christoph Plass, Tania Witte, Charlotte Niemeyer, Miriam Erlacher, Christian Flotho

Blood (2015) 126 (23): 1655.

https://doi.org/10.1182/blood.V126.23.1655.1655

Published: 2015

Journal Articles

CC-122 Repairs T Cell Activation in Chronic Lymphocytic Leukemia That Results in a Concomitant Increase in PD-1:PD-L1 and CTLA-4 Immune Checkpoint Expression at the Immunological Synapse

Benedetta Apollonio, PhD, Mariam Fanous, BSc, MSc, Mohamed-Reda Benmebarek, BSc, MRes, Stephen Devereux, FRCP, FRCPath, PhD, Patrick Hagner, PhD, Michael Pourdehnad, MD, Anita K. Gandhi, PhD, Piers E. Patten, BSc, MRCP, MRCPath, PhD, Alan G. Ramsay, PhD

Blood (2015) 126 (23): 1738.

https://doi.org/10.1182/blood.V126.23.1738.1738

Published: 2015

Journal Articles

Adoptive Transfer of T-Cell-Receptor Engineered Human T Cells Specifically Reduces Viral Titers in HLA-Transgenic NSG Mice Infected with a Humanized Cytomegalovirus

Simone Thomas, MD, Niels Lemmermann, PhD, Sebastian Klobuch, MD, Jürgen Podlech, MD, Matthias Theobald, MD Prof., Matthias J Reddehase, PhD, Wolfgang Herr, MD PhD

Blood (2014) 124 (21): 3834.

https://doi.org/10.1182/blood.V124.21.3834.3834

Published: 2014

Journal Articles

Clinical trials have a home in Blood

Jorge Cortes, Nancy Berliner, Bob Löwenberg

Blood (2014) 123 (25): 3845–3846.

https://doi.org/10.1182/blood-2014-05-560698

Published: 2014

Journal Articles

Conflicts Of Interest In Pharmaceutical Sponsored Research On Erythropoietin Receptors In Cancer: An Updated Analysis

Alyssa Trenery, Samuel Kessler, BA, Van Slooten Eleasa, BS, Akida Lebby, Charles L. Bennett, MD, PhD, MPP, Paul Yarnold, PhD, Paul Ray, DO, MA, Dennis W. Raisch, PhD, MS, RPh, Gowtham Rao, MD, PhD, Peter Georgantopoulos, MPH, MA, LeAnne Norris, PharmD, Simone Boyle, BA, Ashlyn Byrne, Matthew Bialkowski, Oliver Sartor, MD

Blood (2013) 122 (21): 2938.

https://doi.org/10.1182/blood.V122.21.2938.2938

Published: 2013

Journal Articles

Evaluating Conflicts of Interest in Academic Research On Erythropoietin Receptors in the Cancer Setting

Charles Bennett, MD, PhD, MPP, Eleasa vanSlooten, Matthew Bialkowski, Alyssa Trenery, Ashlyn Byrne, Alanna Murday, BS, Paul Yarnold, Zaina Parvez Qureshi, PhD, MPH, A. Oliver Sartor, MD

Blood (2012) 120 (21): 4695.

https://doi.org/10.1182/blood.V120.21.4695.4695

Published: 2012

Journal Articles

Daratumumab, a Novel Therapeutic Human CD38 Monoclonal Antibody, Induces Killing of Refractory Patient-Derived Multiple Myeloma Cells, Growing in a Novel Humanized Mouse MM Model

Willy A Noort, PhD, Richard W.J. Groen, PhD, Reinier Raymakers, MD, PhD, Linda Aalders, Frans M Hofhuis, Berris Van Kessel, Jeroen F Van Velzen, Joost de Bruijn, PhD, Huipin Yuan, PhD, Jeroen Lammerts van Bueren, PhD, Andries C Bloem, PhD, Paul W.H.I. Parren, PhD, Henk Lokhorst, MD, Tuna Mutis, MD PhD, Anton C.M. Martens, PhD

Blood (2012) 120 (21): 940.

https://doi.org/10.1182/blood.V120.21.940.940

Published: 2012

Journal Articles

The Novel, Investigational NEDD8-Activating Enzyme Inhibitor MLN4924 In Adult Patients with Acute Myeloid Leukemia (AML) or High-Grade Myelodysplastic Syndromes (MDS): A Phase 1 Study

Ronan T Swords, MD, MRCPI, FRCPath, Harry P Erba, MD, PhD, Daniel J DeAngelo, MD, PhD, Peter G Smith, PhD, Michael D Pickard, MA, Bruce J. Dezube, MD, Francis J. Giles, MB, MD, FRCPI, FRCPath, Bruno C. Medeiros, MD

Blood (2010) 116 (21): 658.

https://doi.org/10.1182/blood.V116.21.658.658

Published: 2010

Journal Articles

Rifaximin for Preventing Acute Graft Versus Host Disease: Impact On Plasma Markers of Inflammation and T Cell Activation.

Muna Qayed, MD, Amelia Langston, MD, Kuang-Yueh Chiang, MD, PhD, Joseph Hilinski, MD, Conrad Cole, MD, MSc, Stephanie McMillan, RN, Pamela Rowland, RN, MS, CPNP, Andre Rogatko, PhD, John Horan, MD, MPH

Blood (2009) 114 (22): 4664.

https://doi.org/10.1182/blood.V114.22.4664.4664

Published: 2009

Journal Articles

Prevention of Hemophagocytosis by TNF-α and IL-6 Blockade in TLR9- and Nod1- Ligand Induced Hemophagocytic Syndrome.

Hideaki Ohyagi, MD, Nobuyuki Onai, PhD, Yong-Mei Guo, MD, Naoto Takahashi, MD, PhD, Makoto Hirokawa, MD, PhD, Ken-Ichi Sawada, MD, PhD, Toshiaki Ohteki, PhD

Blood (2009) 114 (22): 1351.

https://doi.org/10.1182/blood.V114.22.1351.1351

Published: 2009

Journal Articles

Clinical Trial of NPI-0052 (2nd generation proteasome inhibitor) in Patients Having Advanced Malignancies with Expanded RP2D Cohorts in Lymphoma and CLL

Timothy Price, MD, Peeter Padrik, MD, Amanda Townsend, MD, Paul Mainwaring, MD, Lawrence Catley, MD, Angie M. Longenecker, RN, BSN, Gillian Cropp, MS, Michael A. Palladino, PhD, G. Kenneth Lloyd, PhD, Matthew A. Spear, MD, Michael Millward, MD

Blood (2008) 112 (11): 4934.

https://doi.org/10.1182/blood.V112.11.4934.4934

Published: 2008

Journal Articles

Preclinical Research on Idiotype Vaccine Against B Cell Lymphoma.

Fuxu Wang, Bing Zhao, Ling Pan, Xuejun Zhang, Jianmin Luo, Zuoren Dong

Blood (2006) 108 (11): 4744.

https://doi.org/10.1182/blood.V108.11.4744.4744

Published: 2006

NARROW

PI3Kα/δ Inhibitor, Copanlisib, Inhibits Acute Lymphoblastic Leukemia Cell Growth, Increases Survival and Inhibits CNS Disease Progression in Leukemic Mice

Risk Stratification and Transfusion Dependence Are Independent Risk Factors for Cardiovascular Disease (CVD) in Myelodysplastic Syndrome (MDS)

The Combination of PARP Inhibitors and DNMT Inhibitors Modulates Immune Activity and Suggests a Role for Immune Therapy in AML

Targeting CD20+ Relapsed Refractory B Cell Lymphoma with ACTR087, Antibody-Coupled T-Cell Receptor (ACTR) Engineered Autologous T Cells, in Combination with Rituximab

Alisertib-Induced Polyploidy and Senescence in DH/DP-DLBCL Is Abrogated By Synthetic Lethal Interactions with Ibrutinib and Rituximab

Influence of Different Components of the Tumor Microenvironment on Human Patient-Derived Lymphoma Cell Engraftment in Immmunodeficient Mice

5-Azacytidine Reduces Leukemic Burden in a Xenograft Model of Juvenile Myelomonocytic Leukemia

CC-122 Repairs T Cell Activation in Chronic Lymphocytic Leukemia That Results in a Concomitant Increase in PD-1:PD-L1 and CTLA-4 Immune Checkpoint Expression at the Immunological Synapse

Adoptive Transfer of T-Cell-Receptor Engineered Human T Cells Specifically Reduces Viral Titers in HLA-Transgenic NSG Mice Infected with a Humanized Cytomegalovirus

Clinical trials have a home in Blood

Conflicts Of Interest In Pharmaceutical Sponsored Research On Erythropoietin Receptors In Cancer: An Updated Analysis

Evaluating Conflicts of Interest in Academic Research On Erythropoietin Receptors in the Cancer Setting

Daratumumab, a Novel Therapeutic Human CD38 Monoclonal Antibody, Induces Killing of Refractory Patient-Derived Multiple Myeloma Cells, Growing in a Novel Humanized Mouse MM Model

The Novel, Investigational NEDD8-Activating Enzyme Inhibitor MLN4924 In Adult Patients with Acute Myeloid Leukemia (AML) or High-Grade Myelodysplastic Syndromes (MDS): A Phase 1 Study

Rifaximin for Preventing Acute Graft Versus Host Disease: Impact On Plasma Markers of Inflammation and T Cell Activation.

Prevention of Hemophagocytosis by TNF-α and IL-6 Blockade in TLR9- and Nod1- Ligand Induced Hemophagocytic Syndrome.

Clinical Trial of NPI-0052 (2nd generation proteasome inhibitor) in Patients Having Advanced Malignancies with Expanded RP2D Cohorts in Lymphoma and CLL

Preclinical Research on Idiotype Vaccine Against B Cell Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only